Development and application of an antigen capture ELISA assay for diagnosis of Japanese encephalitis virus in swine, human and mosquito
- Li Mei†1, 2,
- Peng Wu†3,
- Jing Ye1, 2,
- Guangping Gao4,
- Lin Shao1, 2,
- Shaomei Huang1, 2,
- Yaoming Li1, 2,
- Xiaohong Yang1, 2,
- Huanchun Chen1, 2 and
- Shengbo Cao1, 2Email author
© Mei et al; licensee BioMed Central Ltd. 2011
Received: 3 October 2011
Accepted: 6 January 2012
Published: 6 January 2012
Japanese encephalitis (JE) is a serious zoonosis caused by the Japanese encephalitis virus (JEV) which is a mosquito-borne pathogen of the family Flavivirus. However, the application of several developed laboratory methods for the detection of JEV antigens or antibodies are limited by their requirements of laboratory operations, skilled technicians and special facilities.
To develop a method for detecting JEV antigen in swine, human, mosquito and other clinical specimens specifically, conveniently and effectively, an antigen capture enzyme-linked immunosorbent assay (ELISA) was established in this study. Sensitivity, specificity, repeatability and stability of the developed method were evaluated, and 60 clinical samples were tested in this study. The results demonstrated that the antigen capture ELISA was capable in detecting JEV antigen with high sensitivity and specificity compared with conventional methods. 14 samples showed the positive result with coincidence rate of 70%, and 46 displayed negative result with coincidence rate of 100% as compared to that of reverse transcription-polymerase chain reaction (RT-PCR).
The developed ELISA assay provides a convenient and specific method for the large-scale determination of JEV antigen in infected swine, human and mosquito samples with high sensitivity and specificity.
KeywordsJapanese encephalitis Japanese encephalitis virus Monoclonal antibody Polyclonal antibody Antigen capture ELISA
Japanese encephalitis (JE) is a serious mosquito-borne zoonosis caused by the Japanese encephalitis virus (JEV) which threatens public health in southern and eastern Asia. In general, JEV is maintained in a transmission cycle between amplifier swine and vector mosquitoes . As a dead-end, humans are infected by bites of infectious mosquitoes and subsequently develop neurological diseases with an estimated 10,000 JE-related deaths annually [2–5]. As an important pathogen in swine, it also induces terrible consequences in sows reproduction and death in piglets [6, 7].
JEV, a member of the Flaviviridae family, contains a single positive 11-kb RNA genome with three structural proteins and seven nonstructural proteins [8, 9], in which, E protein is the major immunogenic protein of JEV. It has the ability to induce neutralizing antibodies and is recognized as a protein candidate for the development of vaccines and diagnosis methods .
Several laboratory methods have been developed for the detection of JEV infection, such as virus isolation, RT-PCR. However, even with the most advanced laboratory facilities, JEV cannot be isolated from clinical specimens easily, probably because of low circulating viral numbers, soon clearance of transient viremia after onset of illness and the rapid production of neutralizing antibodies [11, 12]; in addition, RT-PCR requires experienced technicians and specialized laboratory equipment, and serological test such as Hemagglutination inhibition test (HI), only could be used to detect serum antibody levels or to monitor the immunization situation. More importantly, these methods are not appropriate for investigating large numbers of samples and detecting of the level of JEV antigens in variety kinds of clinical samples.
Currently, enzyme-linked immunosorbent assay (ELISA) has been used widely for the detection of JEV infection. For example, antibody capture ELISA had been applied to detect IgM of JE in serum , Eiji Konishi established ELISA for quantifying antibodies against JEV nonstructural 1 protein to detect subclinical infections in vaccinated horses , and Sithiprasasna R developed an indirect ELISA for detecting flavivirus antigen in mosquitoes , however, the application of highly specified ELISA method for the detection of JEV antigen in swine, human, mosquito and other clinical samples uniquely and effectively hasn't been reported yet.
In this study, we aimed to develop a highly specific, sensitive, and economical antigen capture ELISA assay for detection of JEV antigen in swine, human, mosquito and other clinical samples, in an attempt to provide an effective tool for diagnosis of JEV infection.
Production and characterization of MAb and PcAb against JEV
Sensitivity of the ELISA assay
1× 106 PFU/ml JEV was serially diluted and tested by ELISA test. As shown in Figure 2, a standard curve for the 10-fold diluted 1 × 106 PFU/ml JEV test was constructed and the homogenate from blank mouse brain was used as the negative control to establish the baseline. The result showed that the minimum virus amount for detection was 1.0 × 104PFU.
Specificity of the ELISA
Specificity of ELISA assay for different virus samples compared with RT-PCR
Repeatability, stability and shelf time of the ELISA assay
Repeatability of ELISA assay for 5 different samples
Detection No. ELISA OD630
Stability of ELISA assay for 5 days at 37°C
(mean + SD)
(mean + SD)
0.894 ± 0.008
0.150 ± 0.012
0.888 ± 0.004
0.145 ± 0.007
0.852 ± 0.027
0.144 ± 0.034
0.796 ± 0.045
0.167 ± 0.051
0.738 ± 0.007
0.129 ± 0.002
Shelf life of ELISA assay at 4°C and -20°C
0.962 ± 0.037
0.168 ± 0.009
0.898 ± 0.058
0.155 ± 0.061
0.934 ± 0.041
0.155 ± 0.014
0.845 ± 0.025
0.147 ± 0.039
0.878 ± 0.014
0.145 ± 0.023
0.797 ± 0.006
0.115 ± 0.011
0.863 ± 0.023
0.127 ± 0.008
0.752 ± 0.009
0.104 ± 0.008
0.856 ± 0.005
0.139 ± 0.012
0.793 ± 0.052
0.113 ± 0.043
0.832 ± 0.034
0.143 ± 0.051
0.721 ± 0.048
0.133 ± 0.029
Clinical sample detection
Results of JEV detection by ELISA assay and RT-PCR for 60 clinical samples
JE is a severe zoonosis which induces fever, aseptic meningitis, acute flaccid paralysis or classic meningomyleoencephalitis, and up to 50% of persons who survive it may have prolonged neurological or psychiatric sequelae [15–18]. Currently, there is an urgent need of a rapid diagnosis method for detection of JEV infection in both humans and animals. Since the inoculation of JEV vaccines contributes to the result of antibody-positive, the accurate diagnosis still depends on the antigen detection. However, the application of conventional methods, such as RT-PCR and viral isolation, are limited by their requirements of laboratory operations, skilled technicians and special equipments. Therefore, a more simple and rapid method for the detection of JEV antigen is needed to be developed.
Herein, we reported a convenient antigen capture ELISA for the diagnosis of JEV infection by using the MAb 4D1 against E protein of JEV and the PcAb of JEV derived from the rabbits. Because the JEV-specific primary antibody and anti-antibody are used, the proposed ELISA in this report is shown to hold the characteristic of detecting JEV antigen specifically, which effectively reduces and clears the interference from other flavivirus for JEV diagnosis. In addition, as the major immunogenic gene, E gene is highly conservative in different JEV genotypes. It has been shown that the E MAb produced by Yaoming Li according to the nucleotide sequence of E gene of JEV genotype III possessed sensitive reaction with prevalence-predominant JEV genotype I , which suggested that our ELISA assay could be applied to clinical detection of different JEV genotypes.
Specific binding between antibody and antigen is the most important factor for the successful development of ELISA assay. In previous studies, specificity of the test has been modified by use of monoclonal antibodies of single strains or multiple strains. However, polyclonal antibodies are typically chosen to enhance sensitivity [19, 20]. Therefore, in this study, the polyclonal antibody rather than the monoclonal antibody against JEV is applied for conjugating with the antigen as detection antibody, since our results have showed that polyclonal antibodies could recognize more JEV strains, which improves the sensitivity of test.
Taken together, the ELISA assay developed in this study has following potential advantages. First, unlike RT-PCR and other viral isolation methods, our ELISA assay does not require expensive reagents and special facilities, and it can be routinely performed in any ordinary laboratory because of its simplicity and rapidity. Second, the ELISA assay has been confirmed with relatively high sensitivity. The minimum detection level of our ELISA assay (1.0 × 104 PFU) is lower than that of RT-PCR (3.2 × 102 PFU), but higher compared with that of immunochromatographic strip (ICS) (2.5 × 105 PFU) . Since the ineluctability of false positive reaction by RT-PCR and the low sensitivity of ICS always prevent the applying of these methods for accurate diagnosis of JEV, our ELISA assay may be developed as an alternative method for fast diagnosis of JEV infection. Additionally, the higher sensitivity with our capture ELISA for detecting JEV antigen than with traditional ELISA has been confirmed in our assay, it could be due to introducing of a horseradish peroxidase (HRP)-labeled goat anti-rabbit antibody for specifically identifying detection antibody, which has amplified the reaction signals in whole system and modified the sensitivity. Most importantly, this ELISA assay provides a convenient way for detecting JEV in a large number of clinical specimens including swine, human and mosquito, which has not been reported before. Therefore, this method will have a broad application prospect in large-scale clinical diagnosis of JEV.
However, there are still some problems cannot be ignored. Samples collected at an appropriate time is required in this ELISA test when the virus in the detected samples has not been degraded. Because the timing of sample collection impacts on the ability to confirm the diagnosis of JEV  and that is necessary for successful detection by any technique. Moreover slight infection with JEV may not be capable of being detected by our ELISA test, it is due to the fact that some samples lightly infected with JEV have negative results with this ELISA but positive results by RT-PCR which has ability to detect lower virus load. Thus the ELISA test in this study is more suitable for diagnosis of severe JEV infection during an exhaustive outbreak in farm. It is necessary that these suspected samples without classical symptom of JEV infection should be further confirmed by other techniques, such as histological, immunological, or molecular assays.
In summary, we successfully developed an antigen capture ELISA assay which could detect JEV antigen in swine, human, mosquito and other samples specifically and effectively, indicating that this ELISA assay could be employed as a fairly simple and efficient tool for clinical detecting and controlling JEV infection.
JEV wide type strain P3 was propagated in brains of suckling mice and the negative control was prepared with the blank mouse brain. Pseudorabies virus (PRV, Ea strain), Porcine circovirus (PCV-2, Yu-A strain), Porcine reproductive and respiratory syndrome virus (PRRSV, YA strain), Porcine parvovirus (PPV), West Nile virus (WNV, inactivated), Classical swine fever virus (CSFV, CWH strain) and Swine influenza virus (SIV) were stored in the laboratory.
The MAb against JEV E protein was produced in our laboratory as reported by Li et al. . The harvested MAb was purified by NAbTM Protein A/G Spin Assay (Thermo Scientific, Rockford, USA) according to the manufacturer's instructions. To produce the PcAb against JEV, rabbits were immunized subcutaneously with emulsified JEV vaccine by Freund's incomplete adjuvant (SIGMA, USA). After the fourth immunization, blood was collected and serum was separated. The PcAb was harvested and purified from the serum. Its activity was characterized by IFA.
The assembling of the ELISA
The MAb was diluted to 5 ug/ml in coating buffer (0.05 M sodium carbonate, pH 9.5-9.7) and added into the 96 wells of polystyrene microtiter plates (KeQian Animal Biological Products Co., Ltd, Wuhan, China). After overnight incubation at 4°C, the plates were washed five times with rinse solution (0.05% Tween-20 in PBS). Nonspecific binding was blocked with blocking solution (1% bovine serum albumin in PBS) at 37°C for 1 h. Subsequently, 100 ul/well of serial diluted samples, were added in. After 30 min of incubation at 37°C, 100 ul of the PcAb against JEV, diluted in 1:10000 by blocking solution, was added as a detection antibody. After another 30 min incubation at 37°C, horseradish peroxidase (HRP)-labeled goat anti-rabbit IgG (BOSTER, Guanshan Road, Wuhan, China) was added and incubated for 30 min. Between each step, plates were washed five times in rinse solution for 2 min. After the conjugation step, tetramethylbenzidine (TMB) was added, and the result was measured by a spectrophotometer at a wavelength of 630 nm.
The cut-off standard and detection criteria of ELISA assay
In this study, a background subtraction method was used as the border value between positive and negative, which referred to the manufacturer's instructions of PRRSV Ab ELISA Manual (Ver.1.0) PRRSV-VR/PRRSV-LA (VDPro, JENO Biotech Inc., Korea).
Test validation: OD mean of positive control (PC):0.4 or above OD mean of negative control (NC):0.2 or less
Calculation of CPC (Corrected Positive Control): CPC = OD mean of PC - OD mean of NC
Calculation of SP (Sample to Positive ratio): SP = (OD mean of sample - OD mean of NC)/CPC
The Cut-off standard of our method was set as follows:
A sample was defined as positive if the SP value was more than 0.4 and as negative if the SP value was less than 0.2. When SP value was between 0.2 and 0.4, the sample was defined to be suspect. If the detection value is suspect, the samples are needed to be collected from the herd after 1 month and tested again for confirmation.
Sensitivity and specificity tests of the ELISA
JEV stock (1 × 106 PFU/ml) was diluted 10-fold successively. Each dilution was applied to the ELISA test. The sensitivity was determined by finding the end point dilution according to the cut-off standard prescribed. The specificity of the ELISA was evaluated by detecting several different viruses including PRV, PCV, PRRSV, PPV, inactivated WNV, CSFV and SIV. 1.0 × 106 PFU/ml JEV strain was used as positive control, while the homogenate from healthy mouse brain was used as negative control.
Repeatability, stability and shelf time evaluation of the ELISA assay
In regard to the repeatability evaluation, the ELISA assay was utilized to detect 3 samples with two groups of coated microtiter plates. Each sample was tested three times separately in one plate for intra-repeat assay and results in two plates were regarded as inter-repeat. The differences were evaluated through comparing variation coefficient and analyzing statistical significance. To analyze the stability of the ELISA assay, the coated polystyrene ELISA plates were placed in 37°C incubator. Standard positive control and negative control were detected by one ELISA plate each day. To determine the shelf life of the ELISA assay, the coated ELISA plates were put into 4°C and -20°C respectively for several months. One piece of the coated plate was used to detect the standard positive control and negative control each month.
Detection of clinical samples in field
60 clinical samples (including 20 mosquito homogenate, 24 swine brain tissues and 16 cerebrospinal fluid of the human patients) were detected by ELISA assay. Among which, 16 cerebrospinal fluid specimens from the human patients at Taihe Hospital (Shiyan, China) were collected on admission; 24 swine brain tissues were collected from clinical detection; 20 mosquito species were caught by the mosquito catcher. The clinical samples from the mosquito, swine, and cerebrospinal fluid were all stored at -80°C before assay. Five grams of brain tissue of swine, mosquitoes in 5 ml of medium were homogenized in a sterile grinder and centrifuged at 10,000 × g for 10 min respectively. The supernatant was filtered with 0.22 um filter membrane and the percolates collected as tissue samples. RT-PCR was applied as the comparative methods.
Statistical analysis was subjected to a Student's t test. P > 0.05 was considered to be no significance of difference.
Japanese encephalitis virus
Enzyme-linked immunosorbent assay
Hemagglutination inhibition test
Reverse Transcription-polymerase chain reaction
Corrected positive control
Sample to positive ratio.
This work was supported by the 973 Project of China (No. 2010CB530100), Natural Science Foundation of China (31172325), Wuhan Chenguang plan (201050231070), Fundamental Research Funds for the Central Universities (2011PY002).
- Konishi E, Shoda M, Ajiro N, Kondo T: Development and evaluation of an enzyme-linked immunosorbent assay for quantifying antibodies to Japanese encephalitis virus nonstructural 1 protein to detect subclinical infections in vaccinated horses. J Clin Microbiol 2004, 42: 5087-5088. 10.1128/JCM.42.11.5087-5093.2004PubMedPubMed CentralView ArticleGoogle Scholar
- Cao QS, Li XM, Zhu QY, Wang DD, Chen HC, Qian P: Isolation and molecular characterization of genotype 1 Japanese encephalitis virus, SX09S-01, from pigs in China. Virol J 2011, 8: 472. 10.1186/1743-422X-8-472PubMedPubMed CentralView ArticleGoogle Scholar
- Weaver SC, Reisen WK: Present and future arboviral threats. Antiviral Res 2010, 85: 328-345. 10.1016/j.antiviral.2009.10.008PubMedPubMed CentralView ArticleGoogle Scholar
- Burke DS, Leake CJ: Japanese encephalitis. In Arboviruses: Epidemiology and Ecology. Volume 3. Edited by: Monath TP. Boca Raton: CRC Press; 1988:63-92.Google Scholar
- Ye XF, Wang HY, Fu SH, Gao XY, Zhao SY, Liu CT, Li MH, Zhai YG, Liang GD: Etiological spectrum of clinically diagnosed Japanese encephalitis cases reported in Guizhou province, China, in 2006. J Clin Microbiol 2010, 48: 1343-1344. 10.1128/JCM.01009-09View ArticleGoogle Scholar
- Van den Hurk AF, Ritchie SA, Mackenzie JS: Ecology and geographical expansion of Japanese encephalitis virus. Annu Rev Entomol 2009, 54: 17-35. 10.1146/annurev.ento.54.110807.090510PubMedView ArticleGoogle Scholar
- World Health Organization: Japanese encephalitis vaccines. Wkly Epidemiol Rec 1998, 73: 334-344.Google Scholar
- Chambers TJ, Hahn CS, Galler R, Rice CM: Flavivirus genome organisation, expression and replication. Annu Rev Microbiol 1990, 44: 649-688. 10.1146/annurev.mi.44.100190.003245PubMedView ArticleGoogle Scholar
- Sumiyoshi H, Mori C, Fuke I, Morita K, Kuhara S, Kondou J, Kikuchi Y, Naqamatu H, Iqarashi A: Complete nucleotide sequence of the Japanese encephalitis virus genome RNA. Virology 1987, 161: 497-510. 10.1016/0042-6822(87)90144-9PubMedView ArticleGoogle Scholar
- Li YM, Hou LD, Ye J, Liu XQ, Dan HB, Jin ML, Chen HC, Cao SB: Development of a convenient immunochromatographic strip for the diagnosis of infection with Japanese encephalitis virus in swine. J Virol Methods 2010, 168: 51-56. 10.1016/j.jviromet.2010.04.015PubMedView ArticleGoogle Scholar
- Solomon T, Thao LT, Dung NM, Kneen R, Hung NT, Nisalak A, Vaughn DW, Farrar J, Hien TT, White NJ, Cardosa MJ: Rapid diagnosis of Japanese encephalitis by using an immunoglobulin M Dot enzyme immunoassay. J Clin Microbiol 1998, 36: 2030-2034.PubMedPubMed CentralGoogle Scholar
- Robinson JS, Featherstone D, Vasanthapuram R, Biggerstaff BJ, Desai A, Ramamurty N, Chowdhury AH, Sandhu HS, Cavallaro KF, Johnson BW: Evaluation of three commercially available Japanese encephalitis virus IgM enzyme-linked immunosorbent assays. AmJTrop Med Hyg 2010,83(5):1146-1155.View ArticleGoogle Scholar
- Zhang MJ, Wang MX, Jiang SZ, Yu BY: A rapid IgM antibody capture ELISA and its employ in the early diagnosis of Japanese encephalitis. Virology 1989, 3: 251-255.Google Scholar
- Sithiprasasna R, Strickman D, Innis BL, Linthicum KJ: ELISA for detecting dengue and Japanese encephalitis viral antigen in mosquitoes. Ann Trop Med Parasitol 1994,88(4):397-404.PubMedGoogle Scholar
- Sarkar A, Taraphdar D, Mukhopadhyay SK, Chakrabarti S, Chatterjee S: Serological and molecular diagnosis of Japanese encephalitis reveals an increasing public health problem in the state of West Bengal, India. Trans R Soc Trop Med Hyg 2011. doi:10.1016/j.trstmh.2011.08.011Google Scholar
- Solomon T, Kneen R, Deng NM, Khanh VC, Thuy TT, Ha DQ, Day NP, Nisalak A, Vauqhn DW, White NJ: Poliomyelitis-like illness due to Japanese encephalitis virus. Lancet 1998, 35: 11094-11097.Google Scholar
- Olsen SJ, Supawat K, Campbell AP, Anantapreecha S, Liamsuwan S, Tunlayadechanont S, Visudtibhan A, Lupthikulthum S, Dhiravibulya K, Viriyavejakul A, Vasiknanonte P, Rajborirug K, Watanaveeradej V, Nabangchang C, Laven J, Kosoy O, Panella A, Ellis C, Henchaichon S, Khetsuriani N, Powers AM, Dowell SF, Fischer M: Japanese encephalitis virus remains an important cause of encephalitis in Thailand. Int J Infect Dis 2010,14(10):e888-e892. 10.1016/j.ijid.2010.03.022PubMedView ArticleGoogle Scholar
- Fischer M, Hills S, Staples E, Johnson B, Yaich M, Solomon T: Japanese encephalitis prevention and control: advances, challenges, and new initiatives. In Emerging Infections 8. Edited by: Scheld WM, Hammer SM, Hughes JM. Washington, DC: ASM Press; 2008:93-124.View ArticleGoogle Scholar
- Ji YY, Guo W, Zhao LP, Li HM, Lu G, Wang Z, Wang GB, Liu CY, Xiang WH: Development of an antigen-capture ELISA for the detection of equine influenza virus nucleoprotein. J Virol Methods 2011, 175: 120-124. 10.1016/j.jviromet.2011.04.016PubMedView ArticleGoogle Scholar
- el-Mekki A, Al-Nakib W, Bibi R: Factors affecting the detection of cytomegalovirus in urine by sandwich enzyme immunoassays. J Virol Methods 1987, 15: 75-83. 10.1016/0166-0934(87)90050-4PubMedView ArticleGoogle Scholar
- Lewthwaite P, Shankar MV, Tio PH, Daly J, Last A, Ravikumar R, Desai A, Ravi V, Cardosa JM, Solomon T: Evaluation of two commercially available ELISAs for the diagnosis of Japanese encephalitis applied to field samples. Trop Med Int Health 2010,15(7):811-818. 10.1111/j.1365-3156.2010.02537.xPubMedView ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.